DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Biopharma (1457)

Category

1457 Biopharma Reports

    LaunchTrends®: Inflectra/Remsima (Wave 2) is the second in a series of...
    LaunchTrends®: Inflectra/Remsima (Wave 2) is the second in a series of syndicated reports designed to track physician perception and uptake of Hospira’s Inflectra and Mundipharma’s Remsima, two different brands of Celltrion’s infliximab biosimilar CT-P13....
    Acute lymphoblastic leukemia (ALL), also known as acute lymphoid leukemia or...
    Acute lymphoblastic leukemia (ALL), also known as acute lymphoid leukemia or cancer of the white blood cells, develops from lymphocytes overproduced in the bone marrow that spread to other sites. Survival in ALL has improved in recent decades, owing mostly to combination chemotherapy, preventive...
    Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and...
    Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinoma in China. The prevalence of this chronic disease remains high owing to the presence of a large existing undiagnosed population and a population of nonresponders (i.e., patients who failed previous...
    Last Updated 30 December 2015In late age-related macular degeneration (AMD),...
    Last Updated 30 December 2015In late age-related macular degeneration (AMD), vision deficits are noticeable, often debilitating, and can be a precursor to blindness. The availability of vascular endothelial growth factor (VEGF) inhibitor therapies delivered via intravitreal injection has...
    Last Updated 29 December 2015Methicillin-resistant Staphylococcus aureus (MRSA)...
    Last Updated 29 December 2015Methicillin-resistant Staphylococcus aureus (MRSA) is a clinically important gram-positive pathogen found in both the hospital and outpatient settings. The recent approvals of oritavancin (The Medicine Company’s Orbactiv), dalbavancin (Allergan’s Dalvance/...
    Last Updated 23 December 2015The psoriasis market has become increasingly...
    Last Updated 23 December 2015The psoriasis market has become increasingly lucrative owing to the growing use of biologics. The dominance of the tumor necrosis factor-alpha (TNF-α) inhibitors is being challenged by the interleukin-12 and 23 (IL-12/23) inhibitor, ustekinumab (...
    Last Updated 23 December 2015Gram-negative infections (GNIs) account for a large...
    Last Updated 23 December 2015Gram-negative infections (GNIs) account for a large portion of hospital-treated infections (HTIs), which represent a high-value segment of the antibacterial market given the severity of these infections. In the past, developers have focused heavily on anti-gram-positive...
    The HIV therapy market is very dynamic. Over the last decade, many effective...
    The HIV therapy market is very dynamic. Over the last decade, many effective antiretroviral (ARV) therapies have been introduced, prompting changes in treatment guidelines and clinical practices. In particular, highly effective and safe agents called integrase strand transfer inhibitors (InSTIs)...
    Crohn’s disease (CD) and ulcerative colitis (UC) are the two gastrointestinal...
    Crohn’s disease (CD) and ulcerative colitis (UC) are the two gastrointestinal inflammatory disorders that constitute inflammatory bowel disease (IBD), affecting approximately 1.25 million people in the United States. Use of biologics is becoming more commonplace in these disorders, with...
    Last Updated 18 December 2015 Treatment options for Crohn’s disease (CD)...
    Last Updated 18 December 2015 Treatment options for Crohn’s disease (CD) include conventional, largely generic small molecules and more-potent biological agents, including tumor necrosis factor-alpha (TNF-α) inhibitors. Despite the clinical and commercial success of the TNF-α...
    This quarterly report series examines the management of dialysis and mid- to...
    This quarterly report series examines the management of dialysis and mid- to late-stage chronic kidney disease (CKD) patients from the perspective of nephrologists. Emphasis is on renal anemia management (erythropoiesis-stimulating agents [ESAs], oral iron, and IV iron), calcium-phosphorus...
    Cystic fibrosis (CF) is a genetic disease affecting chloride transport in a...
    Cystic fibrosis (CF) is a genetic disease affecting chloride transport in a variety of tissues, most notably the lungs and pancreas, and is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. CF is inherited in an autosomal recessive manner, and more than...
    The TreatmentTrends: Psoriasis 2015 (US) report explores treatment dynamics and...
    The TreatmentTrends: Psoriasis 2015 (US) report explores treatment dynamics and their evolution among 100 U.S. dermatologists, through comprehensive primary research methods. The use of biologic products and Otezla prescribed for psoriasis is covered in particular detail. The report explores...
    This quarterly report series examines the current management of unresectable/...
    This quarterly report series examines the current management of unresectable/metastatic malignant melanoma in the United States from the perspective of medical oncologists and explores trends in treatment practices. It enables a greater understanding of medical practice patterns in...
    Hemophilia is a monogenic bleeding disorder occurring primarily in males. In...
    Hemophilia is a monogenic bleeding disorder occurring primarily in males. In hemophilia A and hemophilia B, factor VIII or factor IX (respectively) is either absent or deficient in function. Several factor replacement serums are currently approved to treat hemophilia A and B, but a comparatively...
    LaunchTrends: Zarxio (Wave 1) is the first in a series of syndicated reports...
    LaunchTrends: Zarxio (Wave 1) is the first in a series of syndicated reports designed to track physician perception and uptake of Sandoz’s Zarxio (filgrastim-sndz), a biosimilar of Amgen’s Neupogen and the first biosimilar to launch in the United States. The study surveys medical...
    Last Updated 16 December 2015Parkinson’s disease (PD) is one of the most...
    Last Updated 16 December 2015Parkinson’s disease (PD) is one of the most common chronic neurodegenerative diseases in the elderly; its prevalence is expected to grow 2% annually in the major pharmaceutical markets. The market for PD pharmacotherapies features a high rate of polypharmacy that...
    Duchenne muscular dystrophy (DMD) is the most common form of childhood muscular...
    Duchenne muscular dystrophy (DMD) is the most common form of childhood muscular dystrophies. DMD manifests as muscle degeneration and weakness, and it is histologically characterized by features such as reduction in muscle fiber size and degeneration as well as presence of connective tissue and fat...
    1 - 20 of 1457